Neuigkeiten
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer 19.04.24 · globenewswire | ||
21.03.24 · globenewswire | ||
19.03.24 · globenewswire | ||
15.11.23 · globenewswire | ||
09.10.23 · globenewswire | ||
20.09.23 · globenewswire | ||
|